INVESTIGATING STEROID COATIVATOR 3 (SRC3) AS A POTENTIAL THERAPEUITIC TARGET FOR TRATING ADVANCED PROSTATE CANCER

$80,185FY2011Department of DefenseDOD

Texas A & M University System Health Science Center Research

Investigators